(GENI) Genius Sports - Ratings and Ratios

Genius Sports Ltd (NYSE:GENI) is a technology-driven company that provides innovative products and services to the sports, sports betting, and sports media industries. By leveraging its cutting-edge infrastructure, the company enables the collection, integration, and distribution of live sports data, creating a robust ecosystem for sports leagues, betting operators, and media outlets to capitalize on their content.

The companys comprehensive suite of services includes live data collection, pre-game and in-game odds feeds, risk management solutions, live streaming, and digital marketing campaign optimization. Additionally, Genius Sports offers end-to-end integrity services, utilizing advanced mathematical algorithms to detect and flag suspicious betting activity, thereby protecting the integrity of sports leagues and their associated betting markets.

With a strong presence in the industry, having been founded in 2001 and headquartered in London, UK, Genius Sports has established itself as a key player in the sports technology landscape. Its technology infrastructure and innovative solutions have enabled sports leagues and betting operators to enhance their commercialization strategies, improve fan engagement, and mitigate risk.

Analyzing the technical data, we see that GENIs stock price is currently at $10.47, with a 20-day SMA of $9.76 and a 50-day SMA of $10.00, indicating a potential bullish trend. The 200-day SMA at $8.96 suggests a strong support level. With an ATR of 0.46, representing a 4.35% volatility, the stock has shown a relatively stable price movement. Considering the fundamental data, GENIs market capitalization stands at $2231.37M USD, with a forward P/E ratio of 169.49, indicating high growth expectations. The negative RoE of -7.65% may raise concerns, but it could also be a sign of significant investment in growth initiatives.

Based on the technical and fundamental analysis, a forecast for GENI could be as follows: with the current price above the 50-day SMA and a strong support level at $8.96, we can expect a potential upward trend. If the company continues to demonstrate strong revenue growth and improves its profitability, the stock price could reach the 52-week high of $11.08. However, if the negative RoE persists, it may put downward pressure on the stock price. A potential target price could be around $12.00, representing a 15% increase from the current price, assuming the company continues to execute on its growth strategy and improves its financial performance.